Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
Date:11/10/2008

le operating with a lean overhead structure." Weiss continued, "We expect our cash burn to be approximately $3 million for the remaining three months of 2008, and intend to continue to focus our resources on creating value in our product portfolio."

On Tuesday, November 11, 2008, at 8:30am EST, the Company will host an investor conference call during which they will provide a brief financial overview of the Company's third quarter financial results.

In order to participate in the conference call, please call 1-877-407-8289 (U.S.), 1-201-689-8341 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference call will be available for replay at http://www.keryx.com, for a period of 15 days after the call.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company also has an in-licensing and acquisition program designed to identify and acquire additional dru
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
3. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
5. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
6. Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
7. Bradmer announces 2008 third quarter operational and financial results
8. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
9. TransTech Services Partners Inc. Announces Election of Dr. Ranga C. Krishna as a Director
10. URAC Announces Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards
11. Heska Announces Q3 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... neuropathy is important for the successful treatment of ... Hospital of Kunming Medical University, China, led by ... index for nerve conduction studies in the early ... diabetes mellitus. Nerve conduction studies revealed that distal ... was slower, and sensory nerve action potential and ...
(Date:8/21/2014)... at the University of Montreal, the regions of the ... we train our bodies, movements and, critically, they interact ... knew that sleep helped us the learn sequences of ... subcortical regions are important in information consolidation, especially information ... is measured after a period of sleep, the brain ...
(Date:8/21/2014)... Rebecca Tabbert, owner of Calimesa Fit Body ... enjoyed watching as more people turn away from the ... camp environment. It’s not only good for her business; ... ‘treadmill-dumbbells-elliptical’ routine just doesn’t work,” she says. “Numerous research ... and lifting those cute little dumbbells does very little ...
(Date:8/21/2014)... Chicago, IL (PRWEB) August 21, 2014 ... EB-5 Business & Investment Exploratory Delegation to southern China ... unique opportunity to explore the rapid growing cities of ... each delegate will have the rare opportunity to meet ... their project(s) during a short weeklong time frame. ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Hunhu ... wellness solutions, announced today that it has entered into ... best practices, mobile technology and predictive analytics for recruiting, ... , According to Michael Emerson , co-founder ... for two patents on the technology used in what ...
Breaking Medicine News(10 mins):Health News:Learning to play the piano? Sleep on it! 2Health News:Calimesa Fit Body Boot Camp Announces Its Release of a New Video about the Fitness Boot Camp Experience 2Health News:Calimesa Fit Body Boot Camp Announces Its Release of a New Video about the Fitness Boot Camp Experience 3Health News:Artisan Business Group announces 2014 EB-5 Investment Trade Mission to China 2Health News:Hunhu Healthcare Enters into Licensing Agreement with Mayo Clinic 2
... to the Georgia Banker,s Insurance TrustATLANTA, March 3 ... of the Georgia Bankers Association Insurance Trust (GBAIT), ... Health, a health care data analytics company. ... cost and care management program that integrates wellness, ...
... Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased ... and Drug Administration (FDA) Level II Baseline Inspection and ... It is standard for the FDA to periodically perform ... inspection by the FDA validates the Company,s quality system ...
... a malabsorption syndrome conferring increased risk for various ... is significantly more frequent in patients with newly ... research team led by Dr. Muhammed Hadithi from ... and vitamin B12 daily supplements on homocysteine levels ...
... safe handling, packaging and administration of fluid medications, today announced ... robotics and software company. The ForHealth acquisition adds IntelliFill ... operations management. , ... Englewood, Colo. ...
... PALM BEACH GARDENS, Fla., March 3 Believing ... crucial especially with today,s financial crisis deepening, SilverCensus.com ... for caregivers, senior citizens, and healthcare professionals, announced ... to provide educational support for viewers seeking eldercare ...
... GenCircles, and Family Tree Legends to help ... founder of numerous genealogy companies and products, Cliff Shaw, recently ... "FamilyLink is charting new territory in family social networking ... of this. The growth the company is experiencing, even in ...
Cached Medicine News:Health News:Paragon Benefits, Inc. Selects North Star Health for Data Analysis and Cost Management Reporting 2Health News:Solos Endoscopy, Inc. Successfully Completes FDA Inspection 2Health News:Are vitamin supplements effective in celiac disease patients? 2Health News:Baxa Corporation Acquires Florida-Based ForHealth Technologies™ 2Health News:Baxa Corporation Acquires Florida-Based ForHealth Technologies™ 3Health News:SilverCensus.com Names Consumer Affairs Advocate, Healthcare Experts to Provide Free Educational Support for Seniors 2Health News:FamilyLink.com, Inc. Announces New Lead Developer 2Health News:FamilyLink.com, Inc. Announces New Lead Developer 3
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... 21, 2014  SI-BONE, Inc. ( San Jose, ... the use of the iFuse Implant System, ® ... of the sacroiliac (SI) joint, announced that Priority Health ... its Lumbar Fusion Medical Policy No. 91590-R4 providing positive ... policy states that the fusion procedure, which employs the ...
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful PSE sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 23,478 boxes of ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 2011 As the Joint Select Committee on Deficit Reduction ... the next ten years, the Pharmaceutical Care Management Association ... committee opportunities to leverage greater use of pharmacy benefit management ... costs over that same time period. "Everyone in ...
... Aug. 31, 2011 LifeVantage Corporation (OTCBB: ... supplement, announced today that Douglas C. Robinson, the Company,s ... the Company,s Chief Science Officer, will be presenting at ... be held on September 11-13, 2011, at the Waldorf ...
Cached Medicine Technology:PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee 2PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee 3LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference 2
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
circuitGuard™ Products are available in filter or filter/HME styles., ,High quality air cushion anesthesia masks may be packaged with any circuitGuard™ product....
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
Medicine Products: